Mounjaro approved for blood glucose control in type 2 diabetes

Mounjaro (tirzepatide) injection was approved as an addition to diet and exercise to improve blood glucose control in adults with type 2 diabetes, the U.S. Food and Drug Administration announced May 13.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup